Bérengère Gruson

951 total citations
21 papers, 328 citations indexed

About

Bérengère Gruson is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Bérengère Gruson has authored 21 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Bérengère Gruson's work include Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Bérengère Gruson is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Bérengère Gruson collaborates with scholars based in France, Tunisia and Switzerland. Bérengère Gruson's co-authors include Bruno Royer, Réda Garidi, Gandhi Damaj, A Charbonnier, Marie Brevet, Philippe Rousselot, Claude Preudhomme, Aline Renneville, Olivier Nibourel and Sylvie Castaigné and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Bérengère Gruson

19 papers receiving 322 citations

Peers

Bérengère Gruson
Ant Uzay Türkiye
Jeremy Ramdial United States
Chad P. Soupir United States
Liya Ma China
Mayur Narkhede United States
Bérengère Gruson
Citations per year, relative to Bérengère Gruson Bérengère Gruson (= 1×) peers Cristina N. Alonso

Countries citing papers authored by Bérengère Gruson

Since Specialization
Citations

This map shows the geographic impact of Bérengère Gruson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bérengère Gruson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bérengère Gruson more than expected).

Fields of papers citing papers by Bérengère Gruson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bérengère Gruson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bérengère Gruson. The network helps show where Bérengère Gruson may publish in the future.

Co-authorship network of co-authors of Bérengère Gruson

This figure shows the co-authorship network connecting the top 25 collaborators of Bérengère Gruson. A scholar is included among the top collaborators of Bérengère Gruson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bérengère Gruson. Bérengère Gruson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lebon, Delphine, Alexis Caulier, Magalie Joris, et al.. (2022). Ruxolitinib-induced reactivation of cytomegalovirus and Epstein-Barr virus in graft-versus-host disease. Leukemia Research. 125. 107005–107005. 3 indexed citations
3.
Busson, A, Anne‐Claire Gac, Bérengère Gruson, et al.. (2020). Agriculture et hémopathies malignes chez l’adulte. médecine/sciences. 36. 16–22.
4.
Rabian, Florence, Jérôme Lambert, Daniela Barbieri, et al.. (2020). Eltrombopag in Chronic Myelomonocytic Leukemia (CMML) with Severe Thrombocytopenia: Final Results of a Multicenter Phase II Study. Blood. 136(Supplement 1). 15–16. 2 indexed citations
5.
Philippe, Laure, Maxime Fredon, Sabeha Biichlé, et al.. (2020). BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity. SHILAP Revista de lepidopterología. 2(1). 125–130. 1 indexed citations
6.
Chaussade, H., Guillaume Désoubeaux, Grégory Jouvion, et al.. (2020). Central nervous system candidiasis beyond neonates: Lessons from a nationwide study. Medical Mycology. 59(3). 266–277. 20 indexed citations
7.
Joris, Magalie, et al.. (2019). The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm. Hematological Oncology. 37(4). 487–489. 20 indexed citations
8.
Joris, Magalie, Delphine Lebon, A Charbonnier, et al.. (2019). Immunomodulation with Azacytidine and Donor Lymphocyte Infusion Following Sequential Conditioning Allogenic Stem Cell Transplantation Improves Outcome of Unfavorable AML. Blood. 134(Supplement_1). 4600–4600. 3 indexed citations
10.
Bibault, Jean‐Emmanuel, Martin Figeac, Nathalie Hélevaut, et al.. (2015). Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia. Oncotarget. 6(26). 22812–22821. 43 indexed citations
11.
Paccou, Julien, Éric Desailly, Bérengère Gruson, et al.. (2014). Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study. Annals of Oncology. 25(2). 481–486. 28 indexed citations
12.
Ivanoff, S. S., Bérengère Gruson, Sylvain Chantepie, et al.. (2013). 5‐Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy. American Journal of Hematology. 88(7). 601–605. 40 indexed citations
13.
Leduc, Isabelle, Gandhi Damaj, A Charbonnier, et al.. (2012). Outcome and treatment of 62 Patients Aged Over 75 Years with Low Grade Non Hodgkin Lymphoma. Blood. 120(21). 4854–4854.
14.
Preudhomme, Claude, Nathalie Hélevaut, Olivier Nibourel, et al.. (2011). Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Leukemia Research. 36(3). 316–323. 44 indexed citations
15.
Gruson, Bérengère, Kamel Ghomari, Réda Garidi, et al.. (2011). Long‐term response to rituximab and fludarabine combination in IgM anti‐myelin‐associated glycoprotein neuropathy. Journal of the Peripheral Nervous System. 16(3). 180–185. 33 indexed citations
16.
Guillaume, Nicolas, Dominique Penther, Bérengère Gruson, et al.. (2010). CD66c expression in B‐cell acute lymphoblastic leukemia: strength and weakness. International Journal of Laboratory Hematology. 33(1). 92–96. 16 indexed citations
17.
Lebon, Delphine, Bérengère Gruson, Réda Garidi, et al.. (2009). Bortezomib, Doxorubicin and Dexamethasone (PAD) Prior to High-Dose Melphalan / Autologous Stem Cell Transplantation for Newly Diagnosed Plasma Cell Dycrasias.. Blood. 114(22). 4960–4960. 2 indexed citations
18.
Gruson, Bérengère, et al.. (2008). Drug Rash with Eosinophilia and Systemic Symptoms after Chlorambucil Treatment in Chronic Lymphocytic Leukaemia. Pharmacology. 83(3). 148–149. 8 indexed citations
19.
Gruson, Bérengère, et al.. (2006). Myelofibrosis and cytopenia are not always malignant. European Journal of Internal Medicine. 17(2). 136–137. 5 indexed citations
20.
Brevet, Marie, et al.. (2005). First‐line autologous stem cell transplantation in primary CNS lymphoma. European Journal Of Haematology. 75(4). 288–292. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026